Literature DB >> 15166952

Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling.

Andrea Zambruni1, Ulrich Thalheimer, Gioacchino Leandro, David Perry, Andrew K Burroughs.   

Abstract

Thromboelastography (TEG) with recalcified citrate blood is used as an alternative to native blood, but there is insufficient data regarding sample reliability and stability over time. Thus, TEG parameters of freshly drawn native blood were compared with those of recalcified citrated blood without celite in 10 healthy subjects, and the effect of repeated sampling over 240-min storage was evaluated. All TEG parameters following citrate storage remained stable between 30 min [clot formation time (k) = 7.2 +/- 0.6 min; maximum amplitude (ma) = 48.5 +/- 1.9 mm] and 2 h (k = 7.1 +/- 0.6 min; ma = 46.2 +/- 2.5 mm) after initial sampling, but were not comparable with native blood (k = 9.3 +/- 0.7 min; ma = 43.5 +/- 2.5 mm) at any time point. TEG parameters of repeatedly sampled citrated blood had a significant overall hypercoagulable trend throughout 4 h following sampling. In conclusion, in order to achieve reproducible results, citrated blood without celite may be utilized between 30 min and 2 h following sampling, but in normal subjects the TEG parameters following citrate storage are not comparable with native blood, possibly because of incomplete inhibition of the activation of the coagulation cascade. Thus, citrated blood can be used as a surrogate of native blood in assessing coagulation using TEG, but if repeated sampling is used the trend in hypercoagulability must be considered. Copyright 2004 Lippincott Williams and Wilkins

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166952     DOI: 10.1097/00001721-200401000-00017

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  16 in total

1.  A standardized technique for performing thromboelastography in rodents.

Authors:  Max V Wohlauer; Ernest E Moore; Jeffrey Harr; Eduardo Gonzalez; Miguel Fragoso; Christopher C Silliman
Journal:  Shock       Date:  2011-11       Impact factor: 3.454

Review 2.  Management of Trauma-Induced Coagulopathy with Thrombelastography.

Authors:  Eduardo Gonzalez; Ernest E Moore; Hunter B Moore
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

3.  Thromboelastography values from pigtail macaques ( Macaca nemestrina): effects of age and sex.

Authors:  Derek L Fong; James C Ha; Charlotte E Hotchkiss
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-01       Impact factor: 1.232

4.  The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.

Authors:  Christoph Johannes Schlimp; Janne Cadamuro; Cristina Solomon; Heinz Redl; Herbert Schöchl
Journal:  Blood Transfus       Date:  2012-12-13       Impact factor: 3.443

5.  Development of in situ-forming hydrogels for hemorrhage control.

Authors:  Henry T Peng; Pang N Shek
Journal:  J Mater Sci Mater Med       Date:  2009-04-04       Impact factor: 3.896

Review 6.  Coagulopathy: its pathophysiology and treatment in the injured patient.

Authors:  Brandon H Tieu; John B Holcomb; Martin A Schreiber
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

7.  Preliminary reference intervals and the impact of citrate storage time for thrombelastography in cats including delta and the velocity curve.

Authors:  Carolin Engelen; Andreas Moritz; Franziska Barthel; Natali Bauer
Journal:  BMC Vet Res       Date:  2017-11-29       Impact factor: 2.741

Review 8.  Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation.

Authors:  Luis Teodoro da Luz; Bartolomeu Nascimento; Sandro Rizoli
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-04-16       Impact factor: 2.953

9.  TEG® and ROTEM® in trauma: similar test but different results?

Authors:  Ajith Sankarankutty; Bartolomeu Nascimento; Luis Teodoro da Luz; Sandro Rizoli
Journal:  World J Emerg Surg       Date:  2012-08-22       Impact factor: 5.469

10.  Reduced Transfusion During OLT by POC Coagulation Management and TEG Functional Fibrinogen: A Retrospective Observational Study.

Authors:  Lesley De Pietri; Francesca Ragusa; Annalisa Deleuterio; Bruno Begliomini; Valentina Serra
Journal:  Transplant Direct       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.